PHARMACIE HOUBEN: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMACIE HOUBEN
Largest movements
- Receivables within one year +€28,065
up €28,065 (+41.6%), from €67,540 to €95,605
of which Trade receivables: +€14,335
- Tangible fixed assets -€21,078
down €21,078 (-5.9%), from €355,592 to €334,514
of which Plant, machinery and equipment: -€30,898
- Cash -€9,857
down €9,857 (-29.7%), from €33,239 to €23,382
mainly Receivables within one year (-€28,065) and Investment in fixed assets (net) (-€23,942)
- Stocks and contracts -€6,169
down €6,169 (-4.7%), from €131,603 to €125,434
- Debts after one year -€20,382
down €20,382 (-8.3%), from €244,912 to €224,531
- Trade debts +€8,099
up €8,099 (+28.5%), from €28,462 to €36,561
- Gross operating margin +€6,060
up €6,060 (+4.2%), from €143,023 to €149,083
- Financial charges -€3,343
down €3,343 (-19.6%), from €17,032 to €13,689
- Staff costs +€1,971
up €1,971 (+2.3%), from €84,083 to €86,053
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €592,039 | €584,560 | -€7,479 | -1.3% |
| Fixed assets | 21/28 | €355,592 | €334,514 | -€21,078 | -5.9% |
| Tangible fixed assets | 22/27 | €355,592 | €334,514 | -€21,078 | -5.9% |
| Land and buildings | 22 | €185,445 | €176,734 | -€8,711 | -4.7% |
| Plant, machinery and equipment | 23 | €167,134 | €136,236 | -€30,898 | -18.5% |
| Furniture and vehicles | 24 | €2,587 | €21,545 | +€18,958 | +733% |
| Assets under construction and advance payments | 27 | €426 | - | -€426 | |
| Current assets | 29/58 | €236,447 | €250,045 | +€13,598 | +5.8% |
| Stocks and contracts in progress | 3 | €131,603 | €125,434 | -€6,169 | -4.7% |
| Stocks | 30/36 | €131,603 | €125,434 | -€6,169 | -4.7% |
| Amounts receivable within one year | 40/41 | €67,540 | €95,605 | +€28,065 | +41.6% |
| Trade receivables | 40 | €51,230 | €65,565 | +€14,335 | +28.0% |
| Other amounts receivable | 41 | €16,310 | €30,040 | +€13,729 | +84.2% |
| Cash at bank and in hand | 54/58 | €33,239 | €23,382 | -€9,857 | -29.7% |
| Deferred charges and accrued income | 490/1 | €4,065 | €5,624 | +€1,559 | +38.4% |
| Total equity and liabilities | 10/49 | €592,039 | €584,560 | -€7,479 | -1.3% |
| Equity | 10/15 | €255,782 | €254,553 | -€1,229 | -0.5% |
| Contributions | 10/11 | €168,600 | €168,600 | = | 0.0% |
| Reserves | 13 | €87,150 | €85,150 | -€2,000 | -2.3% |
| Distributable reserves | 133 | €87,150 | €85,150 | -€2,000 | -2.3% |
| Profit (loss) carried forward | 14 | €32 | €803 | +€771 | +2,382% |
| Amounts payable | 17/49 | €336,256 | €330,006 | -€6,250 | -1.9% |
| Amounts payable after more than one year | 17 | €244,912 | €224,531 | -€20,382 | -8.3% |
| Financial debts | 170/4 | €244,912 | €224,531 | -€20,382 | -8.3% |
| Amounts payable within one year | 42/48 | €81,631 | €97,676 | +€16,045 | +19.7% |
| Current portion of amounts payable after more than one year | 42 | €34,175 | €39,918 | +€5,743 | +16.8% |
| Trade debts | 44 | €28,462 | €36,561 | +€8,099 | +28.5% |
| Suppliers | 440/4 | €28,462 | €36,561 | +€8,099 | +28.5% |
| Taxes, remuneration and social security | 45 | €18,994 | €21,196 | +€2,202 | +11.6% |
| Taxes | 450/3 | €7,248 | €8,885 | +€1,637 | +22.6% |
| Remuneration and social security | 454/9 | €11,746 | €12,312 | +€565 | +4.8% |
| Accrued charges and deferred income | 492/3 | €9,713 | €7,800 | -€1,913 | -19.7% |
| Non-recurring operating income | 76A | - | €4,000 | +€4,000 | |
| Remuneration, social security and pensions | 62 | €84,083 | €86,053 | +€1,971 | +2.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €44,165 | €45,020 | +€855 | +1.9% |
| Other operating charges | 640/8 | €4,944 | €4,483 | -€461 | -9.3% |
| Non-recurring operating charges | 66A | €960 | - | -€960 | |
| Gross operating margin | 9900 | €143,023 | €149,083 | +€6,060 | +4.2% |
| Operating profit (loss) | 9901 | €8,871 | €13,527 | +€4,656 | +52.5% |
| Financial income | 75/76B | €1,255 | €2,129 | +€874 | +69.6% |
| Recurring financial income | 75 | €1,255 | €2,129 | +€874 | +69.6% |
| Financial charges | 65/66B | €17,032 | €13,689 | -€3,343 | -19.6% |
| Recurring financial charges | 65 | €17,032 | €13,689 | -€3,343 | -19.6% |
| Profit (loss) for the period before taxes | 9903 | -€6,906 | €1,966 | +€8,872 | |
| Income taxes | 67/77 | €128 | €195 | +€67 | +52.7% |
| Profit (loss) for the period | 9904 | -€7,034 | €1,771 | +€8,805 | |
| Profit (loss) for the period to be appropriated | 9905 | -€7,034 | €1,771 | +€8,805 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 27 October 2026 via checked.be.